Efficacy and Safety of Topiramate in the Treatment of Sleep-Related Eating Disorder

• Status: Completed
• Trial end date: 2018-11-29
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to learn about the safety and effectiveness of oral (taken by mouth) topiramate in treating Sleep-Related Eating Disorder (SRED).

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Massachusetts General Hospital
• Treatments: Topiramate

Criteria

Inclusion Criteria:

• Adults 18-65

• Diagnosis of SRED

• Must be able to swallow capsules and follow instructions

Exclusion Criteria:

• Women who are pregnant or lactating

• Other sleep disorders

• Kidney or Liver disease

• Night shift workers

• Previous history of Topiramate or Topamax use for any condition